Skip to main content
Clinical Trials/IRCT20221214056816N1
IRCT20221214056816N1
Recruiting
Phase 2

Comparison and Combination the effectiveness of transcranial direct current stimulation and varenicline on excutive function, cravings, depression, anxiety and stress in smokers with major depressive disorder

Zanjan University of Medical Sciences0 sites100 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
People with smoking.
Sponsor
Zanjan University of Medical Sciences
Enrollment
100
Status
Recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Having the ability to give informed consent to participate in research
  • Being at least 18 and at most 65 years old
  • Daily consumption of more than ten cigarettes for at least two years(14\)
  • Non\-use of other substances such as: methamphetamine, opioid and benzodiazepine (specified through clinical interview by Ballinger)
  • Having a diagnosis of major depression
  • Failure to consider other severe psychiatric disorders that will be screened through the structured interview of SKID

Exclusion Criteria

  • Consuming more than one marijuana cigarette per week
  • Having a history of neurological diseases such as Parkinson's, epilepsy, convulsions, strokes and cardiovascular problems
  • Having diseases related to the scalp
  • Having a history of head trauma
  • Presence of a device or tool in the head
  • Exiting from the research after absence In two continuous sessions of treatment
  • Pregnancy or breastfeeding

Outcomes

Primary Outcomes

Not specified

Similar Trials